Investigation of Wrightia tinctoria extract activity on Alopecia using In-silco and In-vivo studies

Abstract

There are many drugs for alopecia such as minoxidil, glucocorticoids, sulfasalazine, nitric oxide, and vitamin D3. Hair loss is also known as alopecia, or baldness commonly refers to hair loss from either a portion of a head or body. Fresh Leaves, and bark from twigs of Wrightia tinctoria were taken and used for extraction. A phytochemical assessment was continued to carry out on W.tinctoria extract and the presence of aromatic hydrogen and aromatic protons was demonstrated by spectral characterization. Insilco studies were done. Compounds 1and6 shown more docking values than the minoxidil and Swiss ADME confirmed that the compounds can enter the blood-brain barrier and not the substrates of PgP carriers. In vivo evaluation of alopecia activity using albino male, Wistar rats were done by comparing it with standard drug involves the evaluation of in vivo hair development activities of W.tinctoria extract. It also involves histopathological studies which include the action of hair growth at anagen and telogen phases on 15th and 30th day. The study indicates that the material elements of W.tinctoria which include Quercetin and Indirubin playing a critical role in hair promoting activity.